Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.
Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.
Reduced drug resistance.
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
Solamargine vs cancer
Solamargine vs cancer
The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.
The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.
Best Chemotherapy Adjuvant (1+1>487%)
Effectively improve chemotherapy effect and treatment
ANTI-CANCER
Patent protection in 32 nations.
A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.
A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells.
SR-T100 combination therapy with effective result against breast cancer cells.
Combination Therapy | Research results for lung cancer cells.
A. Chemotherapy (100μM), 16% of cancer cell apoptosis.
B. Alone SM (4.8μM), 28% of cancer cell apoptosis.
C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis.
D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis.
SM has a clearing effect better than Chemotherapy.
The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells.
SM (4.8μM) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times).
SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times).
Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004.
survival rate | cancer | Contents survival rate | cancer | Etymology and definitions survival rate | cancer | Signs and symptoms survival rate | cancer | Local symptoms survival rate | cancer | Systemic symptoms survival rate | cancer | Metastasis survival rate | cancer | Causes survival rate | cancer | Chemicals survival rate | cancer | Diet and exercise survival rate | cancer | Infection survival rate | cancer | Radiation survival rate | cancer | Heredity survival rate | cancer | Physical agents survival rate | cancer | Hormones survival rate | cancer | Autoimmune diseases survival rate | cancer | Pathophysiology survival rate | cancer | Genetics survival rate | cancer | Epigenetics survival rate | cancer | Metastasis survival rate | cancer | Metabolism survival rate | cancer | Diagnosis survival rate | cancer | Classification survival rate | cancer | Prevention survival rate | cancer | Dietary survival rate | cancer | Medication survival rate | cancer | Vaccination survival rate | cancer | Screening survival rate | cancer | Recommendations survival rate | cancer | Genetic testing survival rate | cancer | Management survival rate | cancer | Cancer survival rate | cancer | Radiation survival rate | cancer | Surgery survival rate | cancer | Palliative care survival rate | cancer | Immunotherapy survival rate | cancer | Laser therapy survival rate | cancer | Alternative medicine survival rate | cancer | Prognosis survival rate | cancer | Epidemiology survival rate | cancer | History survival rate | cancer | Society and culture survival rate | cancer | Economic effect survival rate | cancer | Workplace survival rate | cancer | Research survival rate | cancer | Pregnancy survival rate | cancer | Other animals survival rate | cancer | Notes survival rate | cancer | Further reading survival rate | cancer | External links Breast cancer | Triple-negative breast cancer | survival rate | Contents Breast cancer | Triple-negative breast cancer | survival rate | Etymology and definitions Breast cancer | Triple-negative breast cancer | survival rate | Signs and symptoms Breast cancer | Triple-negative breast cancer | survival rate | Local symptoms Breast cancer | Triple-negative breast cancer | survival rate | Systemic symptoms Breast cancer | Triple-negative breast cancer | survival rate | Metastasis Breast cancer | Triple-negative breast cancer | survival rate | Causes Breast cancer | Triple-negative breast cancer | survival rate | Chemicals Breast cancer | Triple-negative breast cancer | survival rate | Diet and exercise Breast cancer | Triple-negative breast cancer | survival rate | Infection Breast cancer | Triple-negative breast cancer | survival rate | Radiation Breast cancer | Triple-negative breast cancer | survival rate | Heredity Breast cancer | Triple-negative breast cancer | survival rate | Physical agents Breast cancer | Triple-negative breast cancer | survival rate | Hormones Breast cancer | Triple-negative breast cancer | survival rate | Autoimmune diseases Breast cancer | Triple-negative breast cancer | survival rate | Pathophysiology Breast cancer | Triple-negative breast cancer | survival rate | Genetics Breast cancer | Triple-negative breast cancer | survival rate | Epigenetics Breast cancer | Triple-negative breast cancer | survival rate | Metastasis Breast cancer | Triple-negative breast cancer | survival rate | Metabolism Breast cancer | Triple-negative breast cancer | survival rate | Diagnosis Breast cancer | Triple-negative breast cancer | survival rate | Classification Breast cancer | Triple-negative breast cancer | survival rate | Prevention Breast cancer | Triple-negative breast cancer | survival rate | Dietary Breast cancer | Triple-negative breast cancer | survival rate | Medication Breast cancer | Triple-negative breast cancer | survival rate | Vaccination Breast cancer | Triple-negative breast cancer | survival rate | Screening Breast cancer | Triple-negative breast cancer | survival rate | Recommendations Breast cancer | Triple-negative breast cancer | survival rate | Genetic testing Breast cancer | Triple-negative breast cancer | survival rate | Management Breast cancer | Triple-negative breast cancer | survival rate | Chemotherapy Breast cancer | Triple-negative breast cancer | survival rate | Radiation Breast cancer | Triple-negative breast cancer | survival rate | Surgery Breast cancer | Triple-negative breast cancer | survival rate | Palliative care Breast cancer | Triple-negative breast cancer | survival rate | Immunotherapy Breast cancer | Triple-negative breast cancer | survival rate | Laser therapy Breast cancer | Triple-negative breast cancer | survival rate | Alternative medicine Breast cancer | Triple-negative breast cancer | survival rate | Prognosis Breast cancer | Triple-negative breast cancer | survival rate | Epidemiology Breast cancer | Triple-negative breast cancer | survival rate | History Breast cancer | Triple-negative breast cancer | survival rate | Society and culture Breast cancer | Triple-negative breast cancer | survival rate | Economic effect Breast cancer | Triple-negative breast cancer | survival rate | Workplace Breast cancer | Triple-negative breast cancer | survival rate | Research Breast cancer | Triple-negative breast cancer | survival rate | Pregnancy Breast cancer | Triple-negative breast cancer | survival rate | Other animals Breast cancer | Triple-negative breast cancer | survival rate | Notes Breast cancer | Triple-negative breast cancer | survival rate | Further reading Breast cancer | Triple-negative breast cancer | survival rate | External links